Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Your ultimate guide to the 2024 North Carolina State Fair
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adlai Nortye Ltd. - American Depositary Shares
(NQ:
ANL
)
1.950
UNCHANGED
Streaming Delayed Price
Updated: 3:54 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Adlai Nortye Ltd. - American Depositary Shares
Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress
August 08, 2024
Company Announces Appointment of Roger Sawhney, M.D. as a New Member of the Board of Directors
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
August 08, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
May 23, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
May 22, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
March 29, 2024
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC
November 17, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award
October 23, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
October 03, 2023
From
Adlai Nortye Ltd.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.